RELENZA

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

ZANAMIVIR MICRONIZED

Mevcut itibaren:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC kodu:

J05AH01

Farmasötik formu:

POWDER FOR INHALATION

Kompozisyon:

ZANAMIVIR MICRONIZED 5 MG

Uygulama yolu:

INHALATION

Reçete türü:

Required

Tarafından üretildi:

GLAXO SMITH KLINE AUSTRALIA PTY LTD

Terapötik grubu:

ZANAMIVIR

Terapötik alanı:

ZANAMIVIR

Terapötik endikasyonlar:

Zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza A and B virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.

Yetkilendirme tarihi:

2017-03-26